Amgen 10K 2010 Annual report | AMGN Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: AAA, ActRule, algorithm, Allred, analytical, AOCI, apportioned, apremilast, Aredia, Arztneimittel, banker, barely, Baton, Bell, Biocon, biosimiliar, BioVex, bisphosphonate, blast, borrowing, breakage, burdensome, byForm, catastrophic, Celgene, Cermeno, confirmatory, Crouse, deadline, demurrer, diaphyseal, disaggregated, disaggregation, disaster, Dittrich, doughnut, drawdown, EC, Epostim, estate, excise, fell, filedForm, fostamatinib, FPL, ganitumab, gap, graft, Greece, Heathcare, hole, imposition, ingredient, INN, inRule, interaction, Interbank, interfering, intolerant, Jackie, Jacqueline, Johnston, Jonathan, KHK, kit, lamellae, leakage, lieu, literature, Litigationaction, Lori, lyophilized, male, McKinsey, melanoma, mid, misleading, Museum, narrowly, necessity, Neugranin, Neukine, Neulasta®and, Neutrovaltm, NHS, nonrecurring, Notwithstanding, Nufil, obligor, odanacatib, ofForm, ofRegulation, oncolytic, onForm, opted, opting, Optiontm, Orencia, osteoporotic, pamidronate, peacock, peginesatide, percent, Petitioner, pled, PMR, poverty, PPACA, Premarket, Pretrial, Pvt, QIAGEN, QIP, Raul, reacquire, real, reconstituting, regulatorily, reject, rejected, rejecting, Religrast, renegotiation, Rigel, rilotumumab, rose, Rouge, rural, score, sequential, settleable, Simonian, slightly, sovereign, spectrum, spring, stakeholder, stringent, stub, Sugar, testimony, theKRASgene, thin, thisForm, threshold, tibial, tofacitinib, toForm, transient, tribunal, UK, undertook, underway, undetected, unsuitable, Urea, vaccine, verify, Victor, visible, volcanic, Waterhouse, wrote, XBRL, XGEVAtm

Removed: accelerate, Albany, Allegany, altered, alternate, amending, AoC, APB, arithmetic, asserted, attaining, awaiting, begun, binder, biomarker, borne, Boulder, Broome, budgeted, career, Cayuga, cervical, chart, Chautauqua, chemoradiotherapy, Chenango, CIA, Cimzia, closure, collectibility, compromise, concurrently, conformance, conservatism, cooperating, Cortland, DAVA, defrauding, designation, differentiate, disposal, double, drop, DSaRMAC, Duramed, EMEA, ensuring, equitable, erythropoietic, Essex, exchanged, exit, FASB, favorably, Fenner, FIFO, Flanagan, focused, force, formulate, Fulton, GBM, Genesee, Genome, glioblastoma, golimumab, Greene, guaranteed, Harrisburg, Hematide, Herkimer, HGS, highest, hyperphosphatemia, impairing, importing, incurring, indefinite, induced, inhibition, integrating, Interference, internally, Iowa, Ireland, iron, Jefferson, Lawrence, Lehman, lessened, leveraged, lymphoid, lymphoma, Madison, materialize, matured, moderated, Monroe, multiforme, Nassau, Niagara, nondeductible, Oneida, Onondaga, Ontario, orally, patented, patenting, periodically, PFS, Pierce, positively, postponement, pre, preventing, protective, Putnam, radiotherapy, ran, rated, regimen, remand, removal, Rensselaer, representing, reset, retention, reversal, Rockland, ruled, safely, Saratoga, SCCHN, scheme, Schuyler, Seneca, Servier, settling, shareholder, simplified, Smith, soft, spread, St, Steuben, sublease, Suffolk, Suisse, TAP, targeted, Task, thereof, unaudited, unenforceable, ustekinumab, vi, vii, voting, Wayne, Wellcome, Westchester, Wyoming


		STATE OR OTHER JURISDICTION OF
SUBSIDIARY		INCORPORATION
(Name under which subsidiary does business)		OR ORGANIZATION
Immunex Corporation		Washington
Amgen Manufacturing, Limited		Bermuda
Amgen USA Inc.		Delaware

Amgen (AMGN) 10-K2010 FY Annual report

Content analysis